The BNT116 vaccine, developed by BioNTech, uses mRNA technology to instruct the immune system to specifically target and destroy lung cancer cells.
Prof Siow Ming Lee stated hopes to usher in a new era for mRNA cancer vaccines, enhancing the effectiveness of standard treatments like immunotherapy and chemotherapy.
Participant Janusz Racz emphasizes the significance of clinical trials, noting that his involvement could pave the way for broader access to such therapies for others.
NHS England's national cancer director highlighted the vaccine's potential as a 'revolutionary' step in lung cancer treatment, marking a significant advancement in vaccination approaches.
[
Collection
]
[
|
...
]